THE USE OF AMLEXANOX IN THE THERAPY OF NEUTROPHIL-DRIVEN DISEASES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120125325A1
SERIAL NO

13375528

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An agent, which is amlexanox, is useful in the therapy of a disease associated with neutrophilia.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOCOPEA LTDLONDON

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bannister, Robin Mark London, GB 64 689
Brew, John London, GB 89 1243

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation